111In-pentetreotide scintigraphy: procedure guidelines for tumour imaging.
other · Level V
Where this comes from
- Record sourced from PubMed, PMID 20461371.
- Also identified by DOI 10.1007/s00259-010-1473-6.
- No licence information is recorded for this record.
- Because redistribution is not established, this page shows the abstract only. Follow the links below for the full text.
Abstract
This document provides general information about somatostatin receptor scintigraphy with (111)In-pentetreotide. This guideline should not be regarded as the only approach to visualise tumours expressing somatostatin receptors or as exclusive of other nuclear medicine procedures useful to obtain comparable results. The aim of this guideline is to assist nuclear medicine physicians in recommending, performing, reporting and interpreting the results of (111)In-pentetreotide scintigraphy.
Medical subject headings
- Neoplasms
- Radionuclide Imaging
- Somatostatin